Table 1 Characteristics of the included CPGs
Authors | Abreviation | Year | Country | Involvement of patients or their representatives | Methodology used to reach recommendations | Methodology used for grading the strength of recommendations | Use of minimally important difference |
|---|---|---|---|---|---|---|---|
Canadian Network for Mood and Anxiety Treatments (CANMAT) | CANMAT | 2016 | Canada | No | CANMAT methodology | CANMAT | No |
Depression Guideline Development Group (Acupuncture CPG) | Acupuncture CPG | 2015 | China | No | GRADE methodology | GRADE | No |
National Collaborating Centre for Mental Health, National Institute for Health and Clinical Excellence (NICE) | NICE | 2018 | United Kingdom | Part of the guideline development group. Does not explicitly state what they did. | GRADE methodology | GRADE | Yes, they discuss the clinical importance of the effects, but a cut-off point is not clearly stated |
Agencia de Evaluación de TecnologÃas Sanitarias de Galicia (GuiaSalud) | GuiaSalud | 2014 | Spain | External validation of guideline | SIGN methodology | SIGN | Yes, they discuss the clinical importance of the effects, but a cut-off point is not clearly stated |
American College of Physicians (ACP) | ACP | 2016 | United States of America | No | Expert consensus | ACP’s GRADE modification | Yes, they discuss the clinical importance of the effects, but a cut-off point is not clearly stated |
American Psychiatric Association (APA) | APA | 2010 | United States of America | No | Expert consensus | APA (appears to be an expert consensus= | No |
Royal Australian and New Zealand College of Psychiatrists | RANZCP | 2018 | Australia New Zealand | No | Not clear | Adaptation of NHMRC | No |
US Preventive Services Task Force Recommendation Statement (US-Task Force) | USTF | 2016 | United States of America | No | Not clear. | USPSTF | Yes, they discuss the clinical importance of the effects, cut-off points are stated (eg. PHQ-9) |
Management of Major Depressive Disorder Working Group (VA/DoD) | VADoD | 2016 | United States of America | No | Expert consensus | GRADE | No |
Korean Guideline Development Team for Depression | Korea | 2014 | Republic of Korea | No | Not clear | SIGN plus their modifications | No |
British Association for Psychopharmacology (BAP) | BAP | 2015 | United Kingdom | No | Expert consensus | BAP criteria | Yes. They state the cut-off points for each effect size measure. |